Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost

An effective human immunodeficiency virus type 1 (HIV-1) vaccine must induce protective antibody responses, as well as CD4(+) and CD8(+) T cell responses, that can be effective despite extraordinary diversity of HIV-1. The consensus and mosaic immunogens are complete but artificial proteins, computa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Virol
Egile Nagusiak: Hulot, Sandrine L., Korber, Bette, Giorgi, Elena E., Vandergrift, Nathan, Saunders, Kevin O., Balachandran, Harikrishnan, Mach, Linh V., Lifton, Michelle A., Pantaleo, Giuseppe, Tartaglia, Jim, Phogat, Sanjay, Jacobs, Bertram, Kibler, Karen, Perdiguero, Beatriz, Gomez, Carmen E., Esteban, Mariano, Rosati, Margherita, Felber, Barbara K., Pavlakis, George N., Parks, Robert, Lloyd, Krissey, Sutherland, Laura, Scearce, Richard, Letvin, Norman L., Seaman, Michael S., Alam, S. Munir, Montefiori, David, Liao, Hua-Xin, Haynes, Barton F., Santra, Sampa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2015
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474309/
https://ncbi.nlm.nih.gov/pubmed/25855741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00383-15
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak